Fortem Financial Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,401
Closed -$36.3K 177
2025
Q4
$36.3K Sell
13,401
-8,600
-39% -$28.2K 0.01% 173
2025
Q3
$93.1K Buy
22,001
+2,000
+10% +$8.79K 0.03% 164
2025
Q2
$99.6K Sell
20,001
-72,222
-78% -$314K 0.03% 168
2025
Q1
$407K Sell
92,223
-26,956
-23% -$127K 0.16% 135
2024
Q4
$554K Buy
119,179
+7,996
+7% +$44K 0.21% 112
2024
Q3
$772K Buy
+111,183
New +$873K 0.31% 93
2021
Q1
Sell
-500
Closed -$20K 265
2020
Q4
$20K Buy
+500
New +$23K 0.01% 313

Other funds holding GDRX

Fortem Financial Group's GDRX Position: Q1 2026 in Review

Fortem Financial Group sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 13,401 shares — an estimated $36.3K sold.

Fortem Financial Group first reported a position in GDRX in Q4 2020 and held it in 7 quarters. The position peaked at $772K in Q3 2024. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Fortem Financial Group reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Fortem Financial Group sold 13,401 GoodRx Holdings shares in Q1 2026, an estimated $36.3K.
  • Fortem Financial Group first reported a position in GoodRx Holdings in Q4 2020 and held it in 7 quarters.
  • Fortem Financial Group's GoodRx Holdings position peaked at $772K in Q3 2024.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Fortem Financial Group's 13F filing for Q1 2026, filed 16 Apr 2026.